Impact of pulsed field versus. radiofrequency on atrial fibrillation ablation workflow and organization: a single high volume center experience [0.03%]
脉冲场消融与射频消融对房颤消融工作流程和组织的影响：单个高容量中心的经验
Davide Ciliberti,Antonio Di Monaco,Federico Quadrini et al.
Davide Ciliberti et al.
Extravascular implantable cardioverter and leadless pacemaker interactions [0.03%]
皮下植入式除颤器与无导线起搏器相互作用
Alfonso Aranda-Hernandez,G Stuart Mendenhall
Alfonso Aranda-Hernandez
Background: Traditional cardiac pacing and defibrillation devices rely on leads connected to a subcutaneous pulse generator, which can result in complications such as vascular damage, infection, or lead failure. Advances ...
Device-lead abnormalities and function after transcatheter tricuspid valve replacement [0.03%]
经导管三尖瓣置换后的设备传导异常和功能问题
Muhannad Abbasi,Ammar M Killu,Christoff Van Niekerk et al.
Muhannad Abbasi et al.
Aims: The increasing adoption of transcatheter tricuspid valve replacement (TTVR) offers a promising therapeutic option for patients with severe tricuspid regurgitation. However, many of these patients have pre-existing c...
Apixaban in Subclinical Atrial Fibrillation: Stroke-Driven Value Amid Economic Uncertainty [0.03%]
无临床症状心房颤动的阿哌沙班：在经济不确定情况下的卒中驱动价值评估
Chung-Hsin Yeh,Shiuan-Chih Chen
Chung-Hsin Yeh
Early substrate-based catheter ablation vs. antiarrhythmic drug therapy for ventricular tachyarrhythmias among patients with prior myocardial infarction: the MANTRA-VT randomized trial [0.03%]
早期基底面导管消融与抗心律失常药物治疗室性心动过速（阵发性室性心动过速和室颤）：MANTRA-VT随机试验
Pekka Raatikainen,Heikki Mäkynen,Juha Hartikainen et al.
Pekka Raatikainen et al.
Aims: Ventricular tachyarrhythmias (VT/VF) are common among patients with prior myocardial infarction (MI). MANTRA-VT trial was designed to compare the efficacy and safety of early substrate-based radiofrequency catheter ...
Randomized Controlled Trial
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2025 Oct 7;27(10):euaf236. DOI:10.1093/europace/euaf236 2025
Genetic variants associated with ventricular arrhythmias during ajmaline test in Brugada syndrome [0.03%]
与Ajmaline试验期间Brugada综合征室性心律失常相关的遗传变异
Charles Audiat,Luigi Pannone,Antonio Sorgente et al.
Charles Audiat et al.
Graphical AbstractPathogenic/Likely Pathogenic variants identified in SCN5A and associated with ajmaline-induced ventricular fibrillation following ACMG guidelines ...
Adherence to oral thromboprophylaxis in atrial fibrillation: An overview for clinicians [0.03%]
房颤口服抗凝治疗的依从性——临床医生概论
Tatjana Potpara,Bogdan Markovic,Marek Grygier et al.
Tatjana Potpara et al.
In most patients with atrial fibrillation, effective stroke prevention necessitates long-term (often lifelong) oral anticoagulant therapy (OAC). However, the effectiveness of OAC therapy in a clinical setting (i.e., outside the controlled e...
Preclinical evaluation of a compliant and absorbable CIED antibacterial envelope [0.03%]
可吸收的符合人体组织的心脏电子设备抗菌包膜的临床前评估研究
Robert D Schaller,Suneet Mittal,Mauro Biffi et al.
Robert D Schaller et al.